CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-30 | Ali Asif Chief Financial Officer | Option exercise 10b5-1 | +9,229 | $38.98 | $360K | 68,232 |
| 2026-09-30 | Ali Asif Chief Financial Officer | Option exercise 10b5-1 | +28,438 | $23.42 | $666K | 96,670 |
| 2026-09-30 | Ali Asif Chief Financial Officer | Option exercise 10b5-1 | +15,650 | $19.19 | $300K | 112,320 |
| 2026-09-30 | Ali Asif Chief Financial Officer | Option exercise 10b5-1 | +5,312 | $12.17 | $65K | 117,632 |
| 2026-09-30 | Ali Asif Chief Financial Officer | Sale 10b5-1 | −12,595 | $141.77 | $1.8M | 105,037 |
| 2026-09-30 | Ali Asif Chief Financial Officer | Sale 10b5-1 | −46,034 | $141.78 | $6.5M | 59,003 |
| 2026-09-30 | Ali Asif Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −9,229 | 29,291 | ||
| 2026-09-30 | Ali Asif Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −28,438 | 49,562 | ||
| 2026-09-30 | Ali Asif Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −15,650 | 51,150 | ||
| 2026-09-30 | Ali Asif Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,312 | 25,235 | ||
| 2026-09-10 | PATEL DINESH V PH D President and CEO | Option exercise 10b5-1 | +7,278 | $21.58 | $157K | 530,246 |
| 2026-09-10 | PATEL DINESH V PH D President and CEO | Sale 10b5-1 | −7,278 | $144.10 | $1.0M | 522,968 |
| 2026-09-10 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −7,278 | 0 | ||
| 2026-09-09 | PATEL DINESH V PH D President and CEO | Option exercise 10b5-1 | +63,548 | $21.58 | $1.4M | 586,516 |
| 2026-09-09 | PATEL DINESH V PH D President and CEO | Sale 10b5-1 | −63,548 | $146.18 | $9.3M | 522,968 |
| 2026-09-09 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −63,548 | 7,278 | ||
| 2026-09-08 | PATEL DINESH V PH D President and CEO | Option exercise 10b5-1 | +54,174 | $21.58 | $1.2M | 577,142 |
| 2026-09-08 | PATEL DINESH V PH D President and CEO | Sale 10b5-1 | −54,174 | $145.87 | $7.9M | 522,968 |
| 2026-09-08 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −54,174 | 70,826 | ||
| 2026-09-03 | PATEL DINESH V PH D President and CEO | Gift | −510 | 522,968 |
Page 1 of 29 · 580 trades